Reading time ( words)
Nordson Corporation announced the appointment of Dr. Milton Morris, recently retired president and chief executive officer of Neuspera Medical, Inc., to its board of directors. Dr. Morris will bring robust business leadership experience, as well as a legacy of successful product innovation, to the board.
“We are pleased to welcome Milton as a new independent director. His passion for innovation and new product development aligns well with Nordson’s strength of understanding customer needs and bringing diversified precision technology solutions to market. In addition, his professional background in medical devices will enhance our understanding, as Nordson plans to further expand acquisitively in this exciting space. We look forward to bringing Milton’s perspective to the board,” said Michael Merriman, chair of the board of directors, Nordson Corporation.
Throughout his career, Dr. Morris has demonstrated a passion for product development that improves people’s lives. He has also led decentralized organizations, growing successful businesses and cultivating diverse and inclusive talent pipelines.
“I look forward to partnering with the Nordson board of directors and executive management team. The company is making solid progress on its Ascend strategy to achieve top tier growth with leading margins and returns. I am excited to reinforce their strong commitment to innovation while also sharing my unique perspective from the medical device industry,” said Dr. Morris.
Dr. Morris’s appointment brings the number of Nordson directors to nine, following the departure earlier this year of Arthur George, who served on Nordson’s board for ten years. Dr. Morris will serve on the board’s audit committee immediately upon appointment.